Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Basel Medical (BMGL) Common Equity (2024 - 2025)

Historic Common Equity for Basel Medical (BMGL) over the last 2 years, with Q2 2025 value amounting to $3.7 million.

  • Basel Medical's Common Equity fell 3313.37% to $3.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.7 million, marking a year-over-year decrease of 3313.37%. This contributed to the annual value of $3.8 million for FY2025, which is 3156.89% down from last year.
  • As of Q2 2025, Basel Medical's Common Equity stood at $3.7 million, which was down 3313.37% from $5.3 million recorded in Q4 2024.
  • Basel Medical's Common Equity's 5-year high stood at $5.6 million during Q2 2024, with a 5-year trough of $3.7 million in Q2 2025.